Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16220992rdf:typepubmed:Citationlld:pubmed
pubmed-article:16220992lifeskim:mentionsumls-concept:C0596402lld:lifeskim
pubmed-article:16220992lifeskim:mentionsumls-concept:C1707391lld:lifeskim
pubmed-article:16220992lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:16220992lifeskim:mentionsumls-concept:C0205198lld:lifeskim
pubmed-article:16220992pubmed:issue21lld:pubmed
pubmed-article:16220992pubmed:dateCreated2005-10-13lld:pubmed
pubmed-article:16220992pubmed:abstractTextThe effects of a few cytotoxic organogold(III) compounds on ovarian A2780 human cancer cells were investigated in comparison to cisplatin and oxaliplatin. The tested compounds produced significant antiproliferative effects and promoted apoptosis to a greater extent than platinum drugs while causing only modest cell cycle modifications. The mechanistic implications of these findings are discussed: mitochondrial pathways are proposed to be directly involved in the apoptotic process in relation to selective inhibition of thioredoxin reductase.lld:pubmed
pubmed-article:16220992pubmed:languageenglld:pubmed
pubmed-article:16220992pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16220992pubmed:citationSubsetIMlld:pubmed
pubmed-article:16220992pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16220992pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16220992pubmed:statusMEDLINElld:pubmed
pubmed-article:16220992pubmed:monthOctlld:pubmed
pubmed-article:16220992pubmed:issn0022-2623lld:pubmed
pubmed-article:16220992pubmed:authorpubmed-author:MessoriLuigiLlld:pubmed
pubmed-article:16220992pubmed:authorpubmed-author:BindoliAlbert...lld:pubmed
pubmed-article:16220992pubmed:authorpubmed-author:CoronnelloMar...lld:pubmed
pubmed-article:16220992pubmed:authorpubmed-author:MiniEnricoElld:pubmed
pubmed-article:16220992pubmed:authorpubmed-author:CinelluMaria...lld:pubmed
pubmed-article:16220992pubmed:authorpubmed-author:GabbianiChiar...lld:pubmed
pubmed-article:16220992pubmed:authorpubmed-author:CaciagliBarba...lld:pubmed
pubmed-article:16220992pubmed:issnTypePrintlld:pubmed
pubmed-article:16220992pubmed:day20lld:pubmed
pubmed-article:16220992pubmed:volume48lld:pubmed
pubmed-article:16220992pubmed:ownerNLMlld:pubmed
pubmed-article:16220992pubmed:authorsCompleteYlld:pubmed
pubmed-article:16220992pubmed:pagination6761-5lld:pubmed
pubmed-article:16220992pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16220992pubmed:meshHeadingpubmed-meshheading:16220992...lld:pubmed
pubmed-article:16220992pubmed:meshHeadingpubmed-meshheading:16220992...lld:pubmed
pubmed-article:16220992pubmed:meshHeadingpubmed-meshheading:16220992...lld:pubmed
pubmed-article:16220992pubmed:meshHeadingpubmed-meshheading:16220992...lld:pubmed
pubmed-article:16220992pubmed:meshHeadingpubmed-meshheading:16220992...lld:pubmed
pubmed-article:16220992pubmed:meshHeadingpubmed-meshheading:16220992...lld:pubmed
pubmed-article:16220992pubmed:year2005lld:pubmed
pubmed-article:16220992pubmed:articleTitleMechanisms of cytotoxicity of selected organogold(III) compounds.lld:pubmed
pubmed-article:16220992pubmed:affiliationDepartment of Pharmacology and Chemistry, University of Florence, Florence, Italy, Department of Chemistry, University of Sassari, Sassari, Italy. marcella.coronnello@unifi.itlld:pubmed
pubmed-article:16220992pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16220992pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16220992lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16220992lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16220992lld:pubmed